Market Access/ News/ News/ News/ Patients Clinuvel gets approval in US for rare skin disorder drug Scenesse Phil Taylor Clinuvel Pharma, erythropoietic protoporphyria, fda, rare disease, Scenesse 0 Comment Australian biotech Clinuvel has claimed a US approval for Scenesse, a treatment for a rare skin disorder that Share X Clinuvel gets approval in US for rare skin disorder drug Scenesse https://pharmaphorum.com/news/clinuvel-gets-approval-in-us-for-rare-skin-disorder-drug-scenesse/